药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Lumiracoxib
Resveratrol
The serum concentration of Resveratrol can be increased when it is combined with Vemurafenib.
Lumiracoxib
Peldesine
The serum concentration of Peldesine can be increased when it is combined with Vemurafenib.
Lumiracoxib
9-Methylguanine
The serum concentration of 9-Methylguanine can be increased when it is combined with Vemurafenib.
Lumiracoxib
Xanthine
The serum concentration of Xanthine can be increased when it is combined with Vemurafenib.
Lumiracoxib
8-azaguanine
The serum concentration of 8-azaguanine can be increased when it is combined with Vemurafenib.
Lumiracoxib
Etoricoxib
The serum concentration of Etoricoxib can be increased when it is combined with Vemurafenib.
Lumiracoxib
Bromazepam
The serum concentration of Bromazepam can be increased when it is combined with Vemurafenib.
Lumiracoxib
Fenethylline
The serum concentration of Fenethylline can be increased when it is combined with Vemurafenib.
Lumiracoxib
Theobromine
The serum concentration of Theobromine can be increased when it is combined with Vemurafenib.
Lumiracoxib
Temafloxacin
The serum concentration of Temafloxacin can be increased when it is combined with Vemurafenib.
Lumiracoxib
Rasagiline
The serum concentration of Rasagiline can be increased when it is combined with Vemurafenib.
Lumiracoxib
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Vemurafenib.
Lumiracoxib
Terodiline
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Terodiline.
Lumiracoxib
Macimorelin
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Macimorelin.
Lumiracoxib
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Deutetrabenazine.
Lumiracoxib
Ivabradine
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ivabradine.
Lumiracoxib
Iloperidone
The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Vemurafenib.
Lumiracoxib
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Vemurafenib.
Lumiracoxib
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Vemurafenib.
Lumiracoxib
Lithium cation
The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Vemurafenib.